SVB Leerink analyst Puneet Souda maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $12 to $15.
BMO Capital Maintains Outperform on Magna International, Lowers Price Target to $65
BMO Capital analyst Peter Sklar maintains Magna International (NYSE:MGA) with a Outperform and lowers the price target from $74 to $65.